Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.
about
Ramadan Fasting and Patients with Cancer: State-of-the-Art and Future ProspectsEngineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer ModelsDNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression.Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.Fasting and Caloric Restriction in Cancer Prevention and Treatment.Protective effects of short-term dietary restriction in surgical stress and chemotherapy.Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages.Fasting and engineered diets as powerful tool in the medical practice: an old approach in the new era.The influence of ketogenic therapy on the 5 R's of radiobiology.To fast, or not to fast before chemotherapy, that is the question.
P2860
Q26767246-ECC32EBD-E63A-4BA3-94D5-2F9C7AF557B4Q33616599-C47AF7BC-1ADA-410C-A53E-31BC3FCD5393Q36672313-95EC8090-5757-4B74-8ABC-E019CF0C750DQ36962474-AAFB9741-116A-4B65-BFDF-4B8366074659Q37109577-92D682C6-8764-4A37-93FF-15D514D27357Q37391981-43CBD42D-4D26-4444-8929-01362E2A4217Q38704674-D743D0FA-37AC-45B5-ACB6-60D80D1CA836Q38936290-E10B029C-A6DD-4C5E-BCA4-FC1DDB66A64FQ39143259-E6980B22-1A69-449E-BB39-EEDAAAAAB00BQ46082155-7580E2AE-8894-4F4B-AEEA-CFB6A482F873Q47130686-5D494F5B-8CEE-4AD9-BF25-93CA57C127E7Q47149772-A7839E6C-3C2C-43A3-9FBE-EDC007CFD7C4Q47987478-0DAB6735-8AC6-4FBF-8F4C-4A4C04E76DD6Q51244186-087C9166-9568-469B-8B7F-3A3358BAC3FB
P2860
Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fasting cycles potentiate the ...... vivo pancreatic cancer models.
@ast
Fasting cycles potentiate the ...... vivo pancreatic cancer models.
@en
type
label
Fasting cycles potentiate the ...... vivo pancreatic cancer models.
@ast
Fasting cycles potentiate the ...... vivo pancreatic cancer models.
@en
prefLabel
Fasting cycles potentiate the ...... vivo pancreatic cancer models.
@ast
Fasting cycles potentiate the ...... vivo pancreatic cancer models.
@en
P2093
P2860
P50
P356
P1433
P1476
Fasting cycles potentiate the ...... vivo pancreatic cancer models
@en
P2093
Chiara Saracino
Concetta Panebianco
Martina D'Aronzo
Paolo Graziano
Stephen P Pereira
P2860
P304
18545-18557
P356
10.18632/ONCOTARGET.4186
P407
P577
2015-07-01T00:00:00Z